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Abstract Na,K-ATPase, an essential transporter of mamma-
lian cells, is an oligomeric transmembrane protein composed of 
two subunits, a and P, of which there are several isoforms. In this 
study, we demonstrate that the a l and oc2 isoforms of the Na,K-
ATPase a subunit are modified by the covalent attachment of 
ubiquitin polymers in COS-7 cells. We propose that polyubiqui-
tination of the Na,K-ATPase a subunit may play a role in 
regulating its degradation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Na,K-ATPase both establishes and maintains the electro-
chemical gradient across the plasma membrane of mammalian 
cells by coupling the hydrolysis of ATP to the transport of 
sodium and potassium ions [1,2]. It is an oligomeric mem-
brane protein composed of two subunits, a and (3, of which 
there are several isoforms [1,2]. The subunit composition of 
the Na,K-ATPase affects its sensitivity to various hormones 
[3] as well as its affinity for cations [4-9] and ouabain, a 
specific inhibitor of the Na,K-ATPase [2]. Both the a and (3 
subunits of Na,K-ATPase are integral membrane proteins 
which are cotranslationally inserted into the membrane of 
the endoplasmic reticulum. Association of the two subunits 
and maturat ion of Na,K-ATPase into a functional transporter 
also occur in this compartment [10-12]. Properly folded cc/|3 
heterodimers enter the secretory pathway and are eventually 
transported to the cell surface, whereas unassembled subunits 
are retained in the endoplasmic reticulum and degraded 
[10,12]. In Xenopus oocytes the half-life of the unassociated 
a subunit (t\/2 ~ 2 h) is 10-fold lower than that of the mature 
oc/p heterodimer [12]. Little, however, is known about the 
mechanism of the degradation of Na,K-ATPase and its indi-
vidual subunits. 
The intracellular degradation of proteins is thought to be 
due primarily to the combined action of the proteasome, a 
multi-subunit cytosolic protease of broad specificity, and the 
lysosome, an acidic compartment of the cell in which numer-
ous proteases and glycosidases are located. The covalent at-
tachment of polyubiquitin chains to proteins frequently serves 
as a signal for their degradation by the proteasome [13]. Orig-
inally, the proteasome was thought to be involved primarily in 
the degradation of soluble cytosolic proteins [13]. Recently, 
however, the proteasome has been implicated in the degrada-
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tion of misfolded proteins which are retained in the endoplas-
mic reticulum [14]. Polyubiquitination of proteins may also be 
involved in the internalization and degradation of plasma 
membrane proteins, a process which may entail the combined 
action of the proteasome and the lysosome [13,15]. 
Here we demonstrate polyubiquitination of both the a l and 
oc2 isoforms of the Na,K-ATPase a subunit in COS-7 cells. 
The Na ,K-ATPase a subunit may therefore be a member of 
the growing list of integral membrane proteins that are de-
graded, at least partially, by the proteasome. 
2. Materials and methods 
2.1. Materials 
All reagents used to culture cells were purchased from Gibco BRL 
(Grand Island, NY). The a l specific polyclonal rabbit antibody 620 
was raised against rat kidney Na,K-ATPase by Dr. Jonathan Lytton 
in this laboratory. The a2 isoform specific polyclonal rabbit antibody 
164 was raised against a peptide corresponding to amino acids 459-
472 of the a2 subunit of Na,K-ATPase by Diana McGill in this 
laboratory. The 12CA5 monoclonal antibody which recognizes the 
influenza virus hemagglutinin epitope was obtained from the Mono-
clonal Antibody Facility of Harvard University (Cambridge, MA). 
Dr. P. Martin-Vasallo (University of Tenerife, Tenerife) kindly pro-
vided us with the [51 specific polyclonal antibody, SPETfil [16]. Fi-
nally, Dr. A.L. Haas (Medical College of Wisconsin, Milwaukee, WI) 
generously provided us with a sample of the affinity-purified rabbit 
polyclonal antibody against SDS purified ubiquitin [17]. 
2.2. Molecular biology 
The wild type cc2 coding sequence was excised from a variant of the 
vector ra2-pKC-4 [4] (obtained from Dr. Jerry Lingrel, University of 
Cincinnati, Cincinnati, OH), blunted, ligated to Pstl linkers, and in-
serted into the Pstl site of the mammalian expression vector pMT2 
[18] (obtained with permission from the Genetics Institute, Cam-
bridge, MA). The substitutions L111R and N122D were introduced 
into a pGem3zf- vector containing the first 673 base pairs of the al 
coding region by the method of Kunkel et al. [19]. The vector rosl-
pKC-4 [20] was also obtained from Dr. Jerry Lingrel. The vector 
pCDNAl FNal was constructed as previously described [21]. Dr. 
Kyung Lim Yoon in our laboratory used a similar strategy to con-
struct pCDNAl FNa2S364P, a vector directing the expression of a 
mutant of the a2 subunit, containing a substitution at serine 364, with 
the influenza virus hemagglutinin epitope fused to its N-terminus. To 
generate an epitope tagged wild type a2 subunit, a restriction frag-
ment containing the epitope tag and the first seven residues of the 
a2S364 coding sequence was used to replace the corresponding frag-
ment of the wild type rx2 subunit cDNA. The resulting epitope tagged 
a2 subunit (FNa2) was subsequently inserted into the mammalian 
expression vector pCDNA I (Invitrogen, San Diego, CA). The coding 
sequence of the N-terminus of FNoc2 is: 
[ influenza virus hemagglutinin cpitopcl L a2 N-terminus 
ATG-GTA-[TAC-CCA TAT GAC-GTC-CCG-GAC-TAC-GCC]-[GGA-CGT-GGG-GCA-GGG-CGT-
met-vai [tyr-pro-tyr-asp-val-pro-asp-tyr-ala]-[gly-arg-glu ala-gly-arg-
2.3. Cell culture and transfection 
COS-7 cells were grown in a humidified incubator with 5% C0 2 at 
37°C in Dulbecco's modified Eagle's medium supplemented with pen-
icillin, glutamine, and 10% fetal bovine serum. 100 mm plates of COS-
7 cells were transfected with 5 (ig of supercoiled plasmid DNA by the 
DEAE dextran method [22] or with the lipofectamine reagent (Gibco 
BRL) according to the manufacturer's instructions. 
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2.4. Preparation of crude membranes 
Four 100 mm plates of transfected COS-7 cells were washed twice 
with 10 ml of phosphate buffered saline (PBS) containing 136.9 mM 
NaCl, 2.7 mM KC1, 8.0 mM Na2HP04, and 1.5 mM KH2P04. Fol-
lowing a 5 min incubation in PBS supplemented with 5 mM Na2ED-
TA, cells were scraped off the plate with a rubber policeman, pelleted 
for 3 min at room temperature at 1000x,g-aT, and resuspended in 2 ml 
of ice-cold hypotonic lysis buffer containing: 50 mM sucrose, 10 mM 
HEPES pH 7.4, 2.5 ug/ml aprotinin, and 1 (ig/ml of leupeptin, chy-
mostatin, and pepstatin. The cells were homogenized by 25 strokes of 
a Dounce homogenizer with a tight pestle. Following the addition of 
246 |il of 65% sucrose (w/w) in 10 mM HEPES pH 7.4 and 4 ul 0.5 M 
MgCl2, the homogenate was subjected to two 10 min spins at 
1000 XgaT at 4°C to pellet nuclei, mitochondria, and unlysed cells. 
Crude membranes were pelleted from the resulting supernatant by 
centrifugation at 100000Xgav for 30 min at 4°C, washed quickly in 
2 ml of hypotonic lysis buffer and resuspended in the same buffer. 
Protein concentration was determined by Peterson's modification of 
the Lowry assay [23]. 
2.5. Fractionation of crude membranes 
The cell fractionation procedure was a modification of the method 
of Saraste et al. [24]. The crude membrane pellet from four 100 mm 
plates of COS-7 cells was resuspended in 0.7 ml of 10 mM HEPES pH 
7.4 with 15 strokes of a Thomas 0448 teflon pestle homogenizer, 
combined with 2.3 ml of 65% (w/w) sucrose in 10 mM HEPES pH 
7.4 to give a final sucrose concentration of 52.5%, and placed at the 
bottom of an SW41 centrifuge tube. The sample was subsequently 
overlaid with 1 ml of the following sucrose solutions: 45%, 40%, 
35%, 30%, 25%, 20%, 15%, and 10% (w/w in 10 mM HEPES pH 
7.4). Following centrifugation at 4°C for 18 h at 84000Xgav, 0.75 
ml fractions were collected from the bottom of the tube, diluted in 
6 ml of ice cold PBS containing 16.5 |ig/ml aprotinin, and spun for 1 h 
at 100000Xgav at 4°C to pellet the membranes. The membrane pellets 
were solubilized directly in 100 |xl of reducing sample buffer. 
2.6. Electrophoresis and immunoblotting 
Samples were solubilized in reducing sample buffer (2% SDS, 10% 
glycerol, 1% P-mercaptoethanol, and 65 mM Tris-HCl pH 6.8) and 
heated for 5-10 min at 65°C prior to loading on SDS polyacrylamide 
gels. Deglycosylation of crude membranes was required to detect the 
COS-7 pi subunit with the polyclonal antibody SPETpl [16]. Crude 
membranes (25 |xg) were mixed with 5% SDS to give a final concen-
tration of 0.1% SDS in 12 ul and denatured by incubating for 3 min at 
65°C. Samples were deglycosylated for 18 h at 37°C in a mixture 
containing: 0.4 units of glycopeptidase F (Calbiochem, La Jolla, 
CA), 15 mM Na2EDTA, 0.75% Nonidet P-40, 20 mM Na2HP04 
pH 7.2, and 10 mM P-mercaptoethanol. Deglycosylation was termi-
nated by the addition of reducing sample buffer. Unless otherwise 
indicated, proteins were transferred to nitrocellulose by the procedure 
of Towbin [25]. To detect ubiquitination, proteins were transferred 
according to Haas [26] for 18 h at 100 mAmp in a buffer containing 
0.01% SDS, 20 mM Tris, and 144 mM glycine. Immunoreactive bands 
were visualized with the Renaissance chemiluminescence reagent (Du-
pont), and immunoblots were stripped according to the enclosed spec-
ifications. 
2.7. Immunoprecipitation 
Epitope tagged a subunits were immunoprecipitated from 1 ml of 
lysate with 2 |j,g of 12CA5 monoclonal antibody and ~ 50 JJ.1 of fresh 
protein A sepharose according to Tamkun and Fambrough [27] with 
the following modifications. The wash with buffer containing 0.1% 
SDS was omitted. Three days post transfection, lysates were prepared 
from 100 mm plates of COS-7 cells. Plates were washed twice in 10 ml 
PBS and the cells solubilized by a 1 h 4°C incubation with gentle 
rocking in 2 ml of extraction buffer containing: 0.5% Triton X-100, 
2 mg/ml bovine serum albumin, 2 mM 7V-ethyl-maleimide, 1 mM 
phenylmethylsulfonyl fluoride, 2.5 |lg/ml aprotinin, 1 |Xg/ml leupeptin, 
1 ng/ml pepstatin, 1 u.g/ml chymostatin, 1 mM EDTA, 150 mM NaCl, 
and 50 mM Tris-HCl pH 7.4. Bound proteins were eluted in reducing 
sample buffer supplemented with 1 mM dithiothreitol for 20 min at 
37°C. Prior to loading, samples were heated for 5 min at 65°C. 
3. Results and discussion 
The endogenous Na,K-ATPase of COS-7 cells is composed 
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of a l (Fig. 1A, lane 1) and (31 subunits (Fig. IB, lane 1). 
Transfection of COS-7 cells with a vector directing expression 
of the rat a l subunit (lane 2 of Fig. 1 A), results in a dramatic 
increase in the amount of a l immunostaining as compared to 
that present in untransfected cells (lane 1 of Fig. 1A) or cells 
expressing the rat a2 subunit (lane 3 of Fig. 1A). In contrast, 
as shown in Fig. IB, the amount of (31 subunit immunostain-
ing is very similar in the three membrane preparations. The 
high levels of expression typically achieved in COS-7 cells [28], 
coupled with our failure to detect an increase in (31 subunit 
expression, suggest that the exogenous rat a subunits consist 
of a mixture of unassembled a subunits and a subunits that 
have been incorporated into functional Na,K-ATPase mole-
cules. 
Ubiquitin is a 76 amino acid (~8.5 kDa) polypeptide that 
is covalently linked to proteins through the formation of an 
isopeptide bond between its carboxyl terminus and the e-ami-
no group of lysine residues [13]. The covalent attachment of 
ubiquitin monomers and polyubiquitin chains of various 
lengths to the cytosolic lysine residues of a polypeptide typi-
cally results in the appearance of a smear or ladder of higher 
molecular weight forms. Because polyubiquitination of pro-
teins serves as a signal for their degradation by the protea-
some, a smear of partially degraded lower molecular weight 
forms is often visible as well [13,26]. We began to suspect that 
the a l subunit was polyubiquitinated when we overexposed 
the immunoblot shown in Fig. 1A. As shown in lane 2 of Fig. 
1C, the a l immunostaining in COS-7 cells expressing rat a l is 
clearly consistent with polyubiquitination of the protein. It is 
strikingly diffuse and comprises a mixture both higher and 
lower molecular weight forms of the protein. 
As shown in lane 3 of Fig. ID, the electrophoretic mobility 
of the rat a2 subunit in crude COS-7 membranes does not 
appear to be heterogeneous. However, when crude mem-
branes are further purified by fractionation over a discontin-
uous sucrose gradient (Fig. IE), a smear of higher molecular 
weight forms of the rat a2 subunit becomes apparent. This 
suggests that the a2 subunit is also polyubiquitinated when it 
is expressed in COS-7 cells. Our difficulty in detecting poly-
ubiquitinated forms of the a2 subunit may be due to the fact 
that our a2 specific antibody, antibody 164, is considerably 
weaker than our a l specific antibody. Another possibility is 
that polyubiquitination interferes with the recognition of the 
a2 subunit by antibody 164. Polyubiquitination can occur at 
multiple cytosolic lysine residues [15,29]. Antibody 164 was 
raised against a lysine containing peptide in the large cytosolic 
loop of the a2 subunit. 
Because Na,K-ATPase frequently aggregates and migrates 
aberrantly in the presence of detergents and reducing agents, 
we were concerned that the high molecular weight forms of 
the a2 and a l subunits could be due to the treatment of our 
samples and not to polyubiquitination. We therefore con-
structed two N-terminally epitope tagged a subunits, FNa l 
and FNa2, and specifically immunoprecipitated the two pro-
teins with a monoclonal antibody against the influenza virus 
hemagglutinin epitope, 12CA5. Introduction of the epitope 
tag does not noticeably interfere with the function of the 
Na,K-ATPase a subunit [21]. 
As shown in Fig. 2Ai, the antibody 12CA5 immunoprecip-
itates a heterogeneous mixture of a l subunits from COS cells 
expressing FNa l . In this particular experiment the 100 kDa 
unmodified form of the F N a l subunit does not constitute a 
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forms of the oc2 subunit are also polyubiquitinated. In 
12CA5 immunoprecipitates from COS-7 cells expressing 
FNoc2, the cc2 specific antibody 164 recognizes a prominent 
band at 100 k D a and a much fainter populat ion of heteroge-
neous high molecular weight population of FNoc2 subunits 
(Fig. 2Bi). Ubiquitin immunostaining clearly correlates with 
the heterogeneous high molecular weight population of FNoc2 
subunits (Fig. 2Bii). 
Clearly the rat a l and oc2 subunits are ubiquitinated in 
COS-7 cells. While it is possible that ubiquitination of the a 
subunit is an artifact of COS-7 expression, we feel this is 
% sucrose in fraction 
Fig. 1. Immunoblots of COS-7 membrane preparations. Electropho-
resis and immunoblotting were carried out as described in Section 
2. The immunoblots shown in A-D represent data from a single set 
of transfection experiments. Crude membranes were prepared from 
COS-7 cells transfected with pMT-2 (lane 1); pKC-4 a l (lane 2) 
and pMT-2 a2 (lane 3) at 3 days post transfection as described in 
Section 2. A: Immunoblot probed with the a l subunit specific poly-
clonal antibody 620. 15 ug of crude membranes were loaded per 
lane. B: Immunoblot probed with the (31 subunit specific antibody, 
SPETpi [16]. To facilitate detection of the COS-7 pi subunit, 25 ug 
of crude membranes per lane were deglycosylated as described in 
Section 2. C: Longer exposure of immunoblot shown in A. D: Im-
munoblot probed with the a2 specific antibody 164. 15 ug of crude 
membranes was loaded per lane. E: Immunoblot of fractions col-
lected from a discontinuous sucrose gradient probed with the a2 
specific antibody 164. Crude membranes prepared from COS-7 cells 
transfected with pMT-2 a2 were fractionated on a discontinuous su-
crose gradient as described in Section 2. The % sucrose present in 
each fraction is shown below the corresponding lane of the immu-
noblot. 
majority of the mixture of FNcel subunits that was immuno-
precipitated. As shown in Fig. 2Aii, the higher molecular 
weight forms of the a l subunit are also recognized by an 
antibody against ubiquitin, indicating that they are polyubi-
quitinated forms of the a l subunit. F N a l subunits conjugat-
ed to shorter polyubiquitin chains are probably not visible at 
this exposure, because both molecular weight and the intensity 
of immunostaining are proport ional to the number of ubiq-
uitin molecules that have been attatched to the F N a l subunit. 
In Fig. 2B we confirm that the higher molecular weight 
Fig. 2. Immunoprecipitation of epitope tagged a l and a2 subunits. 
Lysates of COS-7 cells expressing the N-terminally epitope tagged a 
subunits, FNal and FNa2 were prepared as described in Section 2. 
The cDNAs for the N-terminally epitope tagged a subunits were 
constructed by fusing the sequence of the influenza virus hemagglu-
tinin epitope (YPDVPDYA) to their N-termini as described in Sec-
tion 2. The epitope tagged a subunits were immunoprecipitated 
with the monoclonal antibody 12CA5 and immunoblotted as de-
scribed in Section 2. Immunoblots of 12CA5 immunoprecipitates of 
COS-7 cells transfected with (A) pMT-2 (lane 1) and pKC-4 a l 
(lane 2) or (B) pMT-2 (lane 1) and pMT-2 a2 (lane 2) are shown. 
The immunoblots were probed with (Ai) the a l specific antibody 
620, (Bi) the a2 specific antibody 164, or (Aii and Bii) the ubiquitin 
specific antibody of Haas and Bright [17]. 
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unlikely. The electrophoretic mobility of the a2 subunit in 
HeLa cells is also consistent with polyubiquitination (data 
not shown). 
To our knowledge, this is the first demonstration that the 
Na,K-ATPase cc subunit is ubiquitinated. There are several 
possible functions for the ubiquitination of the a subunit. 
One possibility is that polyubiquitination plays a role in the 
degradation of unassembled a subunits that are retained in 
the endoplasmic reticulum. Misfolded lumenal endoplasmic 
reticulum proteins and a type I integral membrane protein, 
MHC class I, have been shown to be extruded from the en-
doplasmic reticulum, apparently by the same machinery which 
catalyzes the insertion of proteins into the endoplasmic retic-
ulum [14]. In the cytosol, these proteins are subsequently pol-
yubiquitinated and degraded by the proteasome [14]. In con-
trast, polyubiquitinated forms of CFTR, a polytopic 
membrane protein like the Na,K-ATPase a subunit, remain 
associated with the endoplasmic reticulum membrane [30,31]. 
The cytosolic domains of misfolded CFTR molecules are 
ubiquitinated, presumably by an integral endoplasmic reticu-
lum membrane ubiquitin conjugating enzyme such as the 
UBC6 protein of yeast [32], and degraded by the proteasome. 
There is as yet no evidence that the CFTR is translocated 
back across the endoplasmic reticulum membrane. 
As shown in Fig. IE, we have obtained evidence which 
suggests that polyubiquitination may indeed play a role in 
the endoplasmic reticulum associated degradation of unas-
sembled cc2 subunits. In this fractionation experiment, the im-
munostaining of the 100 kDa of the rx2 subunit peaks between 
29% and 32% sucrose, a position consistent with a plasma 
membrane localization (data not shown). In contrast, the 
high molecular weight, presumably polyubiquitinated forms 
of the rx2 subunit peak between 38 and 42%, a density consist-
ent with localization in the endoplasmic reticulum. Clearly, 
further experimentation is required to confirm this hypothesis. 
Polyubiquitination of the a subunit may also play a role in 
the removal of excess and inactive Na,K-ATPase molecules 
from the cell surface. Polyubiquitination has been linked to 
the endocytosis and degradation of a number of plasma mem-
brane proteins [13,15]. In the case of a truncated form of 
Ste2p, a yeast G-protein linked receptor, ubiquitination has 
been shown to be required for its ligand-stimulated endocy-
tosis [15]. The lysosome has also been shown to play an im-
portant role in the degradation of many polyubiquitinated 
plasma membrane proteins [13,15]. Since there is evidence 
that ouabain bound to Na,K-ATPase molecules at the cell 
surface is internalized and degraded in the lysosome [33,34], 
it is likely that ubiquitination of the Na,K-ATPase may be 
involved in this process. 
In conclusion, we have demonstrated that the a l and oc2 
subunits of the Na,K-ATPase are polyubiquitinated in COS-7 
cells. We propose that polyubiquitination may be involved in 
regulating the number of Na,K-ATPase molecules in two 
ways: by promoting the endoplasmic reticulum associated 
degradation of unassembled and misfolded a subunits, and 
by participating in the internalization and subsequent degra-
dation of cell surface Na,K-ATPase molecules. Thus the cell 
maintains a plasma membrane population of functional 
Na,K-ATPase molecules which is able to sustain the sodium 
and potassium gradients essential for viability. 
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